{
"@context": "https://schema.org",
"@type": "Article",
"headline": "AbbVie Files BPCIA Suit Against Boehringer Ingelheim Over Humira® (Adalimumab)",
"url": "https://www.lexblog.com/2017/08/15/abbvie-files-bpcia-suit-boehringer-ingelheim-humira-adalimumab/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-SJANXT0T",
"url": "https://www.lexblog.com/lib/SJANXT0T/"
},
"datePublished": "2017-08-15T22:05:21-04:00",
"dateModified": "2021-11-09T14:01:48-05:00",
"author": {
"@type": "Person",
"name": "Nicole Gifford"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Rothwell Figg"
},
"organizationScope": "at-publication",
"isPartOf": "Biosimilars Law Bulletin",
"about": "Health Care and Life Sciences",
"sourceUrl": "http://www.biosimilarsip.com/?p=4047",
"sourceStability": "may-move"
}